Maria Gabriela Almeida Rodrigues, Patrícia Carvalho Silva Balieiro, Alexandre Vilhena Silva-Neto, Fernando Almeida-Val, Patrícia Takako Endo, Vanderson de Souza Sampaio
{"title":"Clinical and social determinants of COVID-19 lethality and ICU admission across variant waves in the Brazilian Amazon.","authors":"Maria Gabriela Almeida Rodrigues, Patrícia Carvalho Silva Balieiro, Alexandre Vilhena Silva-Neto, Fernando Almeida-Val, Patrícia Takako Endo, Vanderson de Souza Sampaio","doi":"10.1093/ije/dyag190","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The state of Amazonas, located in the Brazilian Amazon, was disproportionately affected during the first waves of the COVID-19 pandemic.</p><p><strong>Methods: </strong>We conducted a population-based cohort study including all confirmed COVID-19 cases (2020-2) in the state of Amazonas, located in northern Brazil, linking data from three surveillance systems with cases of influenza-like illness (ILI) and severe acute respiratory syndrome (SARS). Outcomes included death, intensive care unit (ICU) admission, and a composite severity outcome.</p><p><strong>Results: </strong>Among 420 819 cases, 378 142 (89.9%) had ILI and 42 677 (10.1%) had SARS. A substantial burden of severe outcomes was observed among SARS cases, with ∼25% (n = 8910/35 909) of patients admitted to the ICU, 21.1% (n = 7229/34 323) requiring invasive mechanical ventilation, and 36.7% (n = 14 971/40 837) dying. Male sex [odds ratio (OR) = 1.23; 95% confidence interval (CI): 1.15-1.31; P < .001], age of ≥70 years (OR = 13.73; 95% CI: 11.97-15.76; P < .001), Indigenous ethnicity (OR = 2.32; 95% CI: 1.85-2.91; P < .001), dyspnea (OR = 1.99; 95% CI: 1.82-2.19; P < .001), loss of smell (OR = 1.54; 95% CI: 1.31-1.81; P < .001), and comorbidities, including chronic kidney disease (OR = 1.94; 95% CI: 1.58-2.39; P < .001), chronic respiratory disease (OR = 1.38; 95% CI: 1.08-1.77; P < .05), diabetes (OR = 1.12; 95% CI: 1.03-1.22; P < .05), obesity (OR = 1.31; 95% CI: 1.13-1.51; P < .001), and immunosuppression (OR = 1.90; 95% CI: 1.48-2.44; P < .001), were independently associated with a higher risk of death. Lethality increased significantly during the Gamma wave (OR = 3.76; 95% CI: 3.34-4.24; P < .001).</p><p><strong>Conclusion: </strong>The severity of COVID-19 in Amazonas was shaped by biological, structural, and viral factors, highlighting the need for equitable strengthening of the health system.</p>","PeriodicalId":14147,"journal":{"name":"International journal of epidemiology","volume":"55 5","pages":""},"PeriodicalIF":5.7000,"publicationDate":"2026-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of epidemiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ije/dyag190","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The state of Amazonas, located in the Brazilian Amazon, was disproportionately affected during the first waves of the COVID-19 pandemic.
Methods: We conducted a population-based cohort study including all confirmed COVID-19 cases (2020-2) in the state of Amazonas, located in northern Brazil, linking data from three surveillance systems with cases of influenza-like illness (ILI) and severe acute respiratory syndrome (SARS). Outcomes included death, intensive care unit (ICU) admission, and a composite severity outcome.
Results: Among 420 819 cases, 378 142 (89.9%) had ILI and 42 677 (10.1%) had SARS. A substantial burden of severe outcomes was observed among SARS cases, with ∼25% (n = 8910/35 909) of patients admitted to the ICU, 21.1% (n = 7229/34 323) requiring invasive mechanical ventilation, and 36.7% (n = 14 971/40 837) dying. Male sex [odds ratio (OR) = 1.23; 95% confidence interval (CI): 1.15-1.31; P < .001], age of ≥70 years (OR = 13.73; 95% CI: 11.97-15.76; P < .001), Indigenous ethnicity (OR = 2.32; 95% CI: 1.85-2.91; P < .001), dyspnea (OR = 1.99; 95% CI: 1.82-2.19; P < .001), loss of smell (OR = 1.54; 95% CI: 1.31-1.81; P < .001), and comorbidities, including chronic kidney disease (OR = 1.94; 95% CI: 1.58-2.39; P < .001), chronic respiratory disease (OR = 1.38; 95% CI: 1.08-1.77; P < .05), diabetes (OR = 1.12; 95% CI: 1.03-1.22; P < .05), obesity (OR = 1.31; 95% CI: 1.13-1.51; P < .001), and immunosuppression (OR = 1.90; 95% CI: 1.48-2.44; P < .001), were independently associated with a higher risk of death. Lethality increased significantly during the Gamma wave (OR = 3.76; 95% CI: 3.34-4.24; P < .001).
Conclusion: The severity of COVID-19 in Amazonas was shaped by biological, structural, and viral factors, highlighting the need for equitable strengthening of the health system.
期刊介绍:
The International Journal of Epidemiology is a vital resource for individuals seeking to stay updated on the latest advancements and emerging trends in the field of epidemiology worldwide.
The journal fosters communication among researchers, educators, and practitioners involved in the study, teaching, and application of epidemiology pertaining to both communicable and non-communicable diseases. It also includes research on health services and medical care.
Furthermore, the journal presents new methodologies in epidemiology and statistics, catering to professionals working in social and preventive medicine. Published six times a year, the International Journal of Epidemiology provides a comprehensive platform for the analysis of data.
Overall, this journal is an indispensable tool for staying informed and connected within the dynamic realm of epidemiology.